Humacyte, Inc. announced Robert J. Kossman, MD, FACP, FASN and Prabir Roy-Chaudhury, MD, PhD, FASN have joined the company as advisors.

This company is preparing to file a supplemental Biologic License Application with the Food and Drug Administration after successful Phase III results of the acellular tissue engineered vessel (ATEV) for HD.

Read the full article » | Posted 08-21-2026

Related Articles